What are the contraindications for Succinylcholine (Suxamethonium)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Succinylcholine is contraindicated in patients with a history of malignant hyperthermia, severe burns, crush injuries, spinal cord injuries, neuromuscular diseases, or myopathies due to the risk of life-threatening hyperkalemia. The use of succinylcholine in these conditions can lead to a dangerous hyperkalemic response, potentially causing cardiac arrhythmias or arrest 1.

Conditions to Avoid Succinylcholine

  • Personal or family history of malignant hyperthermia
  • Skeletal muscle myopathies, such as Duchenne muscular dystrophy
  • Hyperkalemia
  • Patients who have sustained major burns, crush injuries, or denervation injuries beyond 48-72 hours post-injury and up to 6 months afterward
  • Penetrating eye injuries
  • Increased intracranial pressure
  • Pseudocholinesterase deficiency

In patients with myopathies like Duchenne muscular dystrophy, succinylcholine may trigger rhabdomyolysis, and its use is absolutely contraindicated due to the risk of fatal reactions 1. For patients with pseudocholinesterase deficiency, the drug's effect can be prolonged from minutes to hours, causing extended paralysis.

Alternative Agents

When succinylcholine is contraindicated but rapid sequence intubation is needed, alternative agents like rocuronium at 1.2 mg/kg can provide comparable intubating conditions. It is essential to consider the patient's medical history and current condition to determine the safest and most effective alternative agent 1.

Key Considerations

  • Monitor patients closely for signs of hyperkalemia, such as cardiac arrhythmias or arrest, when administering succinylcholine
  • Optimize the medical setting and personnel in attendance when patients with contraindications undergo general anesthesia or procedural sedation
  • Have an ICU available for postprocedure care for patients with high-risk conditions 1

From the FDA Drug Label

Succinylcholine is contraindicated in persons with personal or familial history of malignant hyperthermia, skeletal muscle myopathies and known hypersensitivity to the drug. It is also contraindicated in patients after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, because succinylcholine administered to such individuals may result in severe hyperkalemia which may result in cardiac arrest

The contraindications for Succinylcholine (Suxamethonium) are:

  • Personal or familial history of malignant hyperthermia
  • Skeletal muscle myopathies
  • Known hypersensitivity to the drug
  • Patients after the acute phase of injury following:
    • Major burns
    • Multiple trauma
    • Extensive denervation of skeletal muscle
    • Upper motor neuron injury 2

From the Research

Contraindications for Succinylcholine (Suxamethonium)

The following are contraindications for succinylcholine:

  • Hyperkalemia 3, 4, 5, 6
  • Bedridden patients 3
  • Rhabdomyolysis 3
  • Muscle trauma 3
  • Burns 3, 5, 6
  • Infusion of neuromuscular blocking agents 3
  • Acute renal failure 3
  • Chronic renal failure 3
  • Intraocular hypertension 3
  • Intracranial hypertension 3
  • Statin use 3
  • Malignant hyperthermia 3, 6
  • Neuromuscular disease 3, 7, 6
  • Spinal cord sectioning 3
  • Bradycardia < 50 bpm 3, 6
  • Succinylcholine allergy 3
  • Pseudo-cholinesterase deficiency 3, 6
  • Anticonvulsant therapy 7
  • Trauma patients 5
  • Infection 5
  • Immobility 5
  • Acute respiratory acidosis 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.